Spot Trading’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,100
Closed -$19K 4422
2014
Q4
$19K Sell
1,100
-6,500
-86% -$94.6K ﹤0.01% 3597
2014
Q3
$102K Sell
7,600
-45,100
-86% -$537K ﹤0.01% 3510
2014
Q2
$671K Hold
52,700
﹤0.01% 2451
2014
Q1
$627K Buy
52,700
+39,200
+290% +$526K ﹤0.01% 2359
2013
Q4
$186K Buy
13,500
+4,600
+52% +$65K ﹤0.01% 3059
2013
Q3
$155K Sell
8,900
-5,200
-37% -$99.6K ﹤0.01% 3164
2013
Q2
$228K Buy
+14,100
New +$436K ﹤0.01% 2958

Other funds holding INFI

Spot Trading's INFI Position: Q1 2015 in Review

Spot Trading sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2015, closing a stake of 12,134 shares — an estimated $205K sold.

Spot Trading first reported a position in INFI in Q3 2013 and held it in 5 quarters. The position peaked at $449K in Q2 2014. 141 funds tracked by Wall St. Rank hold INFI as of Q1 2015.

  • Spot Trading reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • Spot Trading sold 12,134 Infinity Pharmaceuticals, Inc. shares in Q1 2015, an estimated $205K.
  • Spot Trading first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2013 and held it in 5 quarters.
  • Spot Trading's Infinity Pharmaceuticals, Inc. position peaked at $449K in Q2 2014.
  • 141 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2015.

Based on Spot Trading's 13F filing for Q1 2015, filed 12 May 2015.